Month: August 2024
Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly‘s weight loss drug Zepbound showed benefits in patients with a common type of heart failure and obesity, according to late-stage trial data the company […]
Read MoreAviation market is ‘very strong,’ AerCap CEO says
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Squawk Box Europe Aengus Kelly, CEO of AerCap, discusses the firm’s half-year results and explains why the company has raised its guidance. 02:57 6 minutes ago Source
Read MoreWayfair CEO likens home goods slowdown to 2008 financial crisis: ‘Customers remain cautious’
The first Wayfair brick-and-mortar store prepares to open on May 02, 2024 in Wilmette, Illinois. Scott Olson | Getty Images Online home goods company Wayfair saw sales decline in its fiscal second quarter as its CEO likened the current slowdown in the home goods category to the 2008 financial crisis. “Our credit card data suggests […]
Read MoreBiogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Thursday reported second-quarter earnings and revenue that topped estimates and hiked its full-year guidance, as the company’s cost cuts showed progress and sales of its breakthrough Alzheimer’s drug, Leqembi, and […]
Read MoreModerna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred international revenue into 2025. The biotech company now expects 2024 product revenue to come in between $3 billion to $3.5 […]
Read MoreIsraeli military says it killed Hamas armed wing leader Mohammed Deif in Gaza airstrike last month
A picture taken from Rafah shows smoke billowing over Khan Yunis in the southern Gaza Strip during Israeli bombardment on March 4, 2024, amid ongoing battles between Israel and the Palestinian militant group Hamas. Said Khatib | Afp | Getty Images Israel’s military on Thursday said it killed the chief of Hamas’ military wing, Mohammed […]
Read MoreBank of England to make knife-edge call on interest rates as markets favor cut: Live updates
UK rate decision ‘going to be close’, Goldman Sachs says Goldman Sachs’ chief European economist said Thursday that the Bank of England’s monetary policy decision is “going to be close” while suggesting that a rate cut may win out. Jari Stehn said policymakers were likely to “look through” volatile services inflation and instead focus on […]
Read MoreRolls-Royce shares soar to all-time high on reinstated dividend, raised profit guidance
A Rolls-Royce Trent 700 engine for the Airbus A330 stands in a workshop of N3 Engine Overhaul Services GmbH. The company is a joint venture between Lufthansa Technik AG and Rolls-Royce for the maintenance of aircraft engines. Picture Alliance | Picture Alliance | Getty Images Shares of Rolls-Royce jumped more than 11% to hit an […]
Read MoreBarclays profit dips in the second quarter, beats estimates
One Churchill Place skyscraper, the Barclays Plc headquarters, at Canary Wharf in London, U.K., on Thursday, Jan. 7, 2021. Bloomberg | Bloomberg | Getty Images LONDON — Barclays on Thursday reported second-quarter net profit attributable to shareholders of £1.2 billion ($1.54 billion), slightly lower than a year ago, as the lender’s net interest income in its […]
Read More